Fig. 9From: A Versatile PDA(DOX) Nanoplatform for Chemo-Photothermal Synergistic Therapy against Breast Cancer and Attenuated Doxorubicin-Induced CardiotoxicityAcute toxic profiles of PDA(DOX) nanoparticles via intravenous administration. a Body weight of mice treated with PDA(DOX) within 35 days; b Organ coefficient of mice treated with PDA(DOX) after 35 days; c Blood routine test of mice after sacrifice; d Serum biochemical indices mice after sacrifice; e Major organs photographs of mice treated with PDA(DOX); f H&E staining images of mice major organsBack to article page